Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics


Tandem Diabetes Care, Inc. (TNDM)

Today's Latest Price: $108.18 USD

1.64 (1.54%)

Updated Sep 25 12:10pm

Add TNDM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 138 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TNDM Stock Summary

  • TNDM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 642.13 -- higher than 94.92% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for TNDM is currently 173.83, higher than 98.06% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 912.72%, Tandem Diabetes Care Inc's debt growth rate surpasses 97.81% of about US stocks.
  • Stocks that are quantitatively similar to TNDM, based on their financial statements, market capitalization, and price volatility, are MDLA, ZS, WBAI, CLPS, and AAXN.
  • Visit TNDM's SEC page to see the company's official filings. To visit the company's web site, go to www.tandemdiabetes.com.
TNDM Daily Price Range
TNDM 52-Week Price Range

TNDM Stock Price Chart Technical Analysis Charts


TNDM Price/Volume Stats

Current price $108.18 52-week high $116.89
Prev. close $106.54 52-week low $43.69
Day low $105.53 Volume 232,871
Day high $109.19 Avg. volume 1,219,187
50-day MA $105.67 Dividend yield N/A
200-day MA $83.03 Market Cap 6.59B

Tandem Diabetes Care, Inc. (TNDM) Company Bio


Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.


TNDM Latest News Stream


Event/Time News Detail
Loading, please wait...

TNDM Latest Social Stream


Loading social stream, please wait...

View Full TNDM Social Stream

Latest TNDM News From Around the Web

Below are the latest news stories about Tandem Diabetes Care Inc that investors may wish to consider to help them evaluate TNDM as an investment opportunity.

Hedge Funds Are Buying Tandem Diabetes Care Inc (TNDM) Again

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of June 30th, when the S&P 500 Index was trading around the […]

Yahoo | September 15, 2020

The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp ...

Benzinga | September 3, 2020

The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG ) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Catalent Inc (NYSE: CTLT ) Evogene Ltd (NASDAQ: EVGN ) (announced $10 million equity investment led by ARK Investment Management) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 1) Acasti Pharma Inc (NASDAQ: ACST ) ADiTx Therapeutics...

Benzinga | September 2, 2020

Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present a company update at the following virtual investor conferences: Wells Fargo 2020 Healthcare Conference on Wednesday, September 9, 2020 at 12:00pm Eastern Time (9:00am Pacific Time), Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 at 11:45a

Business Wire | September 2, 2020

Benzinga's Top Upgrades, Downgrades For August 20, 2020

Upgrades * For Cinemark Holdings Inc (NYSE: CNK), Benchmark upgraded the previous rating of Hold to the current rating Buy. For the second quarter, Cinemark Hldgs had an EPS of $1.27, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $39.81 and a 52-week-low of $5.71. At the end of the last trading period, Cinemark Hldgs closed at $11.14. * For OGE Energy Corp (NYSE: OGE), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. OGE Energy earned $0.51 in the second quarter, compared to $0.50 in the year-ago quarter. The stock has a 52-week-high of $46.43 and a 52-week-low of $23.00. At the end of the last trading period, OGE Energy closed at $32.08. * According to Northland Capital Markets, the prior rating for Power Integrations Inc (N...

Yahoo | August 20, 2020

Read More 'TNDM' Stories Here

TNDM Price Returns

1-mo 0.76%
3-mo 25.30%
6-mo 58.13%
1-year 77.32%
3-year 1,559.20%
5-year 5.95%
YTD 81.48%
2019 56.99%
2018 1,508.90%
2017 -89.02%
2016 -81.80%
2015 -7.01%

Continue Researching TNDM

Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:

Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8477 seconds.